Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Leukemia|June 1, 1995
Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemiasH D Menssen, H J Renkl, U Rodeck, et al.Oncogene|September 20, 2005
Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growthM R Bhonde, M-L Hanski, M Notter, et al.Leukemia & Lymphoma|October 1, 1996
Peripheral blood progenitor cell mobilization with Dexa-Beam/G-CSF, ether lipid purging, and autologous transplantation after high-dose CBV treatment: a safe and effective regimen in patients with poor risk malignant lymphomasW U Knauf, M P Koenigsmann, M Notter, et al.Transplantation|May 8, 2000
An interleukin-2-IgG-Fas ligand fusion protein suppresses delayed-type hypersensitivity in mice by triggering apoptosis in activated T cells as a novel strategy for immunosuppressionS Bulfone-Paus, R Rückert, H Krause, et al.Cancer Research|July 14, 1998
Vaccination with tumor cells engineered to secrete interleukin 2-immunoglobulin G fusion protein induces tumor rejectionS Bulfone-Paus, H von Bernuth, R Rückert, et al.International Journal of Oncology|May 17, 2011
Interleukin-4 inhibits growth of a human lung-tumor cell-line in-vitro and has therapeutic activity against xenografts of this cell-line in-vivoM Topp, M Koenigsmann, A Miresluis, et al.Bone Marrow Transplantation|September 1, 1996
Chemopurging of peripheral blood-derived progenitor cells by alkyl-lysophospholipid and its effect on haematopoietic rescue after high-dose therapyM P Koenigsmann, M Notter, W U Knauf, et al.Blood|November 1, 1993
Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivoM S Topp, M Koenigsmann, A Mire-Sluis, et al.International Journal of Radiation Oncology, Biology, Physics|February 1, 1997
Pediatric medulloblastoma: radiation treatment technique and patterns of failureR Miralbell, A Bleher, P Huguenin, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2009
Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trialS Luminari, A Montanini, D Caballero, et al.Pageof 6